5
Pharmaceuticals and pharmaceutical products for treating muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
42
Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
44
Providing a website and information in the field of rare and infectious diseases; providing a website and information in the field of the diagnosis and treatment of muscular dystrophy and Duchenne muscular dystrophy; providing a website and information in the field of medicine via electronic and optical communications networks
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen